INTER-TUMOR HETEROGENEITY OF PD-L1 EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER AND ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA AMONG PATIENTS IN ALEXANDRIA, EGYPT

GENE PROFILING OF LUNG CANCER AMONG NON- SMALL CELL LUNG CANCER PATIENTS IN ALEXANDRIA, EGYPT

PROGNOSTIC VALUE OF PD-L1 TUMOR EXPRESSION IN EGYPTIAN PATIENTS WITH EPITHELIAL BLADDER CANCER

GERMLINE BREAST CANCER SUSCEPTIBILITY GENES MUTATION(BRCA) AND EXPRESSION OF PROGRAMMED DEATH LIGAND-1(PDL-1) IN TRIPLE-NEGATIVE BREAST CANCER EGYPTIAN PATIENTS AND CORRELATION W

Outcome of Patients with Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases: Egyptian Experience

BACTERIAL INFECTION PROFILES AND TUMOR BIOMARKERS IN EGYPTIAN LUNG CANCER PATIENTS

Haplotyping of PD-1 Polymorphisms in Egyptian Patients with Colorectal Cancer: A Case-Control Study.

PD-L1 Expression in Colorectal Cancer and Its Relation to Microsatellite Instability and Cytotoxic Tumor-Infiltrating Lymphocytes

CLINICOPATHOLOGICAL SIGNIFICANCE OF PROGRAMED DEATH -LIGAND -1(PD-L1) AND PROLIFERATION CELL NUCLEAR ANTIGE(PCNA)EXPRESSION IN PROSTATIC CARCINOMA; AN IMMUNOHISTOCHEMICAL STUDY"

Expression of programmed death ligand 1 (PD-L1) in urothelial bladder carcinoma (immunohistochemical and histopathological study)